Innovation Pharmaceuticals Inc (IPIX)

[Cognition]

Agreed. One step closer. Great news!

“We now have a Phase 3-ready drug candidate targeting an area of large unmet need—comprising a worldwide annual market opportunity estimated to approach $1 billion—for which currently there are no FDA-approved treatments. Brilacidin is further advantageously differentiated from the two other OM drug candidates in Phase 3 testing which require being taken intravenously, whereas Brilacidin is easily administered as an oral rinse and conveniently packaged in sachet form, similar in design to a sugar packet. With a sachet, patients simply would mix the contents of the Brilacidin sachet with water for a quick-and-easy treatment at home or on-the-go.”

Patients and Insurers are going to love B! IMO
What a pain in the a$$ competitor’s treatments are. Patients that are going through so much pain already don’t need anymore added. They don’t have to go to a hospital to have it administered. They can stay home and rest. Advantage IPIX. Partnership coming IMO.